Ftd - OmicsDI

Show results for

Unknown (1774)
Genomics (249)
Transcriptomics (199)
Proteomics (75)
Metabolomics (16)
Other (11)
Clinical (10)
Methylation profiling (5)

Organisms

Homo sapiens (167)
Mus musculus (72)
Schizosaccharomyces pombe (57)
Oryza sativa Indica Group (57)
Sinorhizobium meliloti BL225C (57)
Sus scrofa domesticus (57)
Ostreococcus tauri (57)
Saccharomyces cerevisiae (57)
Staphylococcus aureus (57)
Rattus norvegicus (57)
Escherichia coli (57)
Cyanophora paradoxa (57)
Entamoeba histolytica (57)
Physcomitrium patens (57)
Methylohalobius crimeensis 10Ki (57)
Homo sapiens (57)
Lotus japonicus (57)
Shigella flexneri (57)
Ctenopharyngodon idella (57)
Danio rerio (57)
Allexis (57)
Shigella (57)
Pseudomonas putida KT2440 (57)
Helicobacter pylori 26695 (57)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (57)
Drosophila melanogaster (11)
Caenorhabditis elegans (3)
feces metagenome (1)
Escherichia coli (1)
Rattus norvegicus (1)

Organisms

Homo sapiens (115)
Mus musculus (47)
Drosophila melanogaster (7)
Caenorhabditis elegans (2)
feces metagenome (1)
Rattus norvegicus (1)
Escherichia coli (1)

Repository

ENA (219)
geo (176)
pride (57)
biostudies-arrayexpress (54)
EGA (15)
MetaboLights (15)
MassIVE (10)
jPOST (5)
iProX (3)
GNPS (1)

Tissue

Brain (24)
Cell culture (13)
Cerebrospinal fluid (5)
Pluripotent stem cell (4)
Permanent cell line cell (4)
Neuron (3)
Cerebral cortex (2)
Spinal cord (2)
Brainstem motor neuron (1)
Central nervous system neuron (1)
Primary cerebral cortical neuronï¿½ (1)
Primary motor neuron (1)
Neuron of cerebral cortex (1)
Lymphocyte (1)
Neuroblast (1)
Cortex (1)
Motor neuron (1)
Epithelial cell of lung (1)
HiPSC cell (1)
Hippocampus (1)
Microglial cell (1)
Nerve cord (1)
Skin (1)
Diploid cell (1)
Blood serum (1)
Cell suspension culture (1)
Stem cell (1)
Fibroblast (1)
Primary cell (1)
Hippocampal neuron (1)

Disease

Amyotrophic lateral sclerosis (17)
Frontotemporal dementia (10)
Alzheimer's disease (3)
Colorectal cancer (3)
FTDALS1 (3)
Colorectal cancer (2)
Colorectal Neoplasms (2)
Histologically or cytologically confirmed UICC stage IV carcinoma of colon or rectum with metastasis (metastatic colorectal cancer) with need for treatment due to progression (1)
Colorectal Cancer (1)
Neoplasms (1)
Semantic dementia (1)
Frontotemporal dementia (1)
Tauopathy (1)
Progressive supranuclear palsy (1)
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (1)
Frontotemporal dementia and/or amyotrophic lateral sclerosis-3 (1)
Dementia (1)
Parkinson's disease (1)
Disease free (1)

Technology Type

Mass Spectrometry (57)
Shotgun proteomics (30)
Mass spectrometry (15)
Affinity purification coupled with mass spectrometry proteomics (12)
Bottom-up proteomics (10)
SWATH MS (5)
Data-independent acquisition (5)
Data-dependent acquisition (5)
SRM/MRM (2)
ILLUMINA, Illumina HiSeq 2500 (1)
NMR spectroscopy (1)
DiaPASEF (1)
Gel-based experiment (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (9)
Liquid Chromatography MS - positive - reverse phase (8)
Illumina NovaSeq 6000 (4)
Q Exactive HF-X (3)
Illumina HiSeq 2000 (2)
Orbitrap Fusion Lumos (2)
Liquid Chromatography MS - negative (2)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
MinION (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
TripleTOF 6600 (1)
LTQ Orbitrap XL (1)
TimsTOF Pro (1)
LTQ Orbitrap Elite (1)
Orbitrap Eclipse (1)
Q Exactive (1)
Direct infusion MS - negative (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Direct infusion MS - positive (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - alternating - hilic (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2025 (49)
2023 (44)
2024 (35)
2026 (27)
2022 (27)
2021 (24)
2020 (22)
2019 (15)
2014 (14)
2018 (13)
2013 (12)
2016 (11)
2012 (7)
2017 (6)
2015 (5)
2011 (3)
2010 (3)
2008 (1)

CHEBI ID

CHEBI:27897 (6)
CHEBI:28044 (6)
CHEBI:16411 (5)
CHEBI:17295 (5)
CHEBI:17351 (5)
CHEBI:15318 (5)
CHEBI:16704 (5)
CHEBI:16449 (5)
CHEBI:16919 (5)
CHEBI:17368 (5)
CHEBI:26271 (5)
CHEBI:18237 (5)
CHEBI:17154 (5)
CHEBI:18186 (5)
CHEBI:27452 (4)
CHEBI:17768 (4)
CHEBI:24813 (4)
CHEBI:28790 (4)
CHEBI:16196 (4)
CHEBI:9300 (4)
CHEBI:18295 (4)
CHEBI:7916 (4)
CHEBI:30769 (4)
CHEBI:73024 (4)
CHEBI:17822 (4)
CHEBI:25017 (4)
CHEBI:17847 (3)
CHEBI:17626 (3)
CHEBI:16422 (3)
CHEBI:18243 (3)

Metabolite Name

Alanine (4)
Proline (4)
Linoleic acid (4)
Hypoxanthine (4)
Leucine (3)
Cortisol (3)
Arachidonic acid (3)
Sebacic acid (3)
Tryptophan (3)
Tyrosine (3)
Phenylalanine (3)
Glutamic acid (3)
Adenine (3)
Creatine (3)
L-Histidine (3)
L-Arginine (3)
L-Phenylalanine (3)
Xanthine (3)
Uridine (3)
Alpha,beta-Didehydrotryptophan (2)
PC(18:2/18:2) (2)
Lauric acid (2)
N-Methyltryptamine (2)
Psilocybin (2)
Urocanate (2)
Homostachydrine (2)
N-Methylserotonin (2)
3'-AMP (2)
PC(16:0/0:0) (2)
Phenylacetaldehyde (2)

First Public Date

2025 (45)
2023 (32)
2026 (26)
2024 (26)
2020 (21)
2022 (16)
2021 (13)
2019 (13)
2018 (9)
2014 (6)
2015 (4)
2017 (3)
2016 (3)
2013 (2)

Classification

bacteria (1)

Study status

Completed (4)
Recruiting (3)
Active, not recruiting (2)
Suspended (1)

Study type

Transcription profiling by array (24)
RNA-seq of coding RNA (18)
Interventional (8)
RNA-seq of total RNA (4)
Methylation profiling by array (3)
Other (2)
Observational (2)
ChIP-seq (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of non coding RNA (1)

Release Date

2023 (225)
2025 (212)
2021 (202)
2022 (193)
2024 (185)
2020 (173)
2019 (135)
2018 (111)
2017 (77)
2016 (69)
2015 (57)
2014 (47)
2013 (38)
2012 (31)
2026 (27)
2011 (14)
2009 (11)
2010 (7)
2008 (6)
2007 (2)
2006 (2)
2003 (1)
2001 (1)

Lab affiliation

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (3)
Head of Laboratory of Neuro-Oncology, Neurology, Clinical & Cancer Proteomics (2)
Systems Biology Ireland, University College Dublin (2)
Department of Biomedical Sciences, University of Padova, Italy CNR-Neuroscience Institute, Italy Padova Neuroscience center, University of Padova, Italy (1)
Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada. Department of Chemistry, The University of Western Ontario, London, Ontario, Canada. (1)
Max Planck Institute for Biology of Ageing Joseph-Stelzmann-Str. 9b 50931 Cologne, Germany (1)
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW, 2109, Australia (1)
MRC Laboratory of Molecular Biology, Neurobiology division, Cambridge, UK (1)
Neurodegeneration Pathobiology Laboratory, Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia (1)
University of Zurich Department of Quantitative Biomedicine (1)
Department of Pathology, University of California, San Francisco. San Francisco, CA, USA. Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. (1)
UK Dementia Research Institute at University of Edinburgh, University of Edinburgh, Edinburgh bioQuarter, Chancellor’s Building, 49 Little France Crescent, Edinburgh, EH16 4SB UK (1)
Assistant Professor of Neurology and Angela Dobson and Lyndon Welch Professor of Neurology Department of Neurology | University of Michigan Health System 109 Zina Pitcher Place, 5015 BSRB | Ann Arbor, MI | 48109 (1)
Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. Department of Pathology, University of California, San Francisco, San Francisco, CA, USA. (1)
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. (1)
Center for Alzheimer’s Disease and Related Dementias (CARD) National Institutes of Health (NIH) (1)
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA (1)
Laboratory of neurobiology and pathology, Department of Cellular, Computational and Integrative Biology (DeCIBIO), University of Trento, Italy (1)
Department of Neuropathology, Medical Research institute and Center for Brain Integration Research, Tokyo Medical and Dental University, Japan (1)
Munich Cluster of Systems Neurology, LMU Munich, Germany (1)
King’s BHF Centre, King’s College London, London, UK (1)
Institute of Biochemistry II, Faculty of Medicine, Goethe University Frankfurt, Frankfurt, Germany. (1)
Motor Neuron Disease Research Centre, Macquarie University, NSW, 2113, Australia (1)
Division of Systems and Cellular Medicine School of Medicine University of Dundee (1)
Clem Jones Centre of Aging Dementia Research, Queensland Brain Institute, University of Queensland (1)
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Johns Hopkins University School of Medicine (1)
Department of Cell Biology Harvard Medical School Boston, MA USA (1)
Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK (1)
University College London | UCL · Division of Infection and Immunity (1)
Proteomics and Metabonomics Laboratory,Experimental Neuroscience Department, IRCCS-S.Lucia Foundation, Roma , Italy (1)

Location

Japan (6)
Asia except Japan (2)
Taiwan (1)
Greece (1)
United Kingdom (1)
Germany (1)

Keyword

Trifluridine (2)
Metastatic colorectal cancer, Panitumumab, TAS-102 (1)
Digestive System Diseases (1)
Gastrointestinal Diseases (1)
Gastrointestinal Neoplasms (1)
Lonsurf (1)
Antineoplastic Agents (1)
Panitumumab (1)

Previous page
1 / 234
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 234
Next page

Sort by:

Relevance

Page size

Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.

Multiple FTD patient-specific iPSC lines were generated for the first time, Human neurons of progranulin haploinsufficiency have been established. PGRN S116X neurons are more sensitive to kinase inhibitors-induced cell stress, which can be rescued by ectopic progranulin expression, revealing progran...

ORGANISM(S): Homo sapiens

2012-10-25 | E-GEOD-40378 | biostudies-arrayexpress

Fusion discovery in breast cancer cell line

SnowShoes-FTD, a fusion transcript discovery tool, was used to identify fusions in breast cancer cell lines using the RNA-Seq data Total RNA extracted from cell lines. The total RNA was used for construction of RNA-Seq library for RNA-Sequencing.

ORGANISM(S): Homo sapiens

2013-11-22 | E-GEOD-52643 | biostudies-arrayexpress

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.

Not available

S-EPMC7310563 | biostudies-literature

CAGE-seq of human post-mortem brain tissue of the frontal lobe from patients with FTD and healthy controls

Understanding the molecular mechanisms underlying frontotemporal dementia (FTD) is essential for the development of successful therapies. Systematic studies on human post-mortem brain tissue of patients with genetic subtypes of FTD are currently lacking. The Risk and Modyfing Factors of Frontotempor...

ORGANISM(S): Homo sapiens

2023-02-26 | E-MTAB-12646 | biostudies-arrayexpress

RNA-seq of human post-mortem brain tissue of the frontal lobe from patients with FTD and healthy controls

ORGANISM(S): Homo sapiens

2023-02-17 | E-MTAB-12647 | biostudies-arrayexpress

C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD

Noncoding expansions of a hexanucleotide repeat (GGGGCC) in the C9orf72 gene are the most common cause of familial amyotrophic lateral sclerosis and frontotemporal dementia. Here we report transgenic mice carrying a bacterial artificial chromosome (BAC) containing the full human C9orf72 gene with ei...

ORGANISM(S): Mus musculus

2016-02-10 | E-GEOD-77720 | biostudies-arrayexpress

Whole exome sequencing in patients with ALS and concomitant FTD lacking the C9orf72 repeat expansion

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are part of a clinical, pathological and genetic continuum. The purpose of the present study was to assess the mutation burden that is present in ALS and/or FTD known disease-causing genes in 54 patients (16 with available postmor...

EGAS00001002439 | EGA

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.

Not available

S-EPMC10630271 | biostudies-literature

Differential Toxicity of Nuclear RNA Foci Versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS

Nuclear RNA foci are often associated with mis-regulation of RNA processing in repeat expansion diseases. Here we report transcriptomic analysis of flies carrying expanded G4C2 repeats, the most common genetic cause of FTD/ALS. By obtaining an average of 32 million reads per library, we show that th...

ORGANISM(S): Drosophila melanogaster

2015-09-11 | E-GEOD-72771 | biostudies-arrayexpress

ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ

Recently, we identified missense mutations in CCNF that are causative of familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). CCNF encodes for cyclin F, a substrate recognition component of an E3-ubiquitin ligase. Mutations in CCNF directly implicates disrupti...

ORGANISM(S): Homo sapiens (Human)

2021-03-18 | PXD014163 | Pride

Previous page
1 / 234
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 234
Next page

Sort by:

Relevance

Page size

2339 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets